CHAPEL HILL, N.C., March 31, 2011 /PRNewswire/ -- Paul Meade, the president and founder of Thought Leader Select, a Research Triangle, NC company focused on facilitating medical expert collaborations with the biopharmaceutical and other healthcare industries, has accepted an invitation to speak at the annual meeting of the American Association of Clinical Endocrinologists (AACE).
The 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists will take place from April 13-17 in San Diego, CA. At the invitation of AACE President-Elect Dr. Yehuda Handelsman, Meade will speak during the annual Corporate AACE Partner (CAP) meeting, an opportunity for physicians and representatives from partnering companies, including biopharmaceutical and medical device firms, to learn about emerging topics in inter-industry collaborations in medicine.
Meade's speech, "Interactions in the Age of Transparency," will outline a new path forward for even better industry collaborations with medical experts based on a foundation of ethics and transparency. "I am honored to accept the invitation from Dr. Handelsman and the AACE," stated Meade. "I have built my career on the basis of an unwavering commitment to ethics and transparency. We have to remember that we're all in this together—health care providers, researchers, and people from industry—to promote better health for everyone in this country. If we always keep patients' best interest in mind and work together is an open and fair manner, we all win!"
About Paul Meade
Paul Meade is the founder and president of Thought Leader Select and Clear Point Health, companies that serve various industries within healthcare. In May of 2010, Meade completed his Master of Public Health degree with an ethics certificate from the Gillings School for Global Public Health at the University of North Carolina at Chapel Hill.
About Thought Leader Select
Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as "thought leaders" and "key opinion leaders") within a host of therapeutic areas such as diabetes, oncology, and neurology.
Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
|SOURCE Thought Leader Select|
Copyright©2010 PR Newswire.
All rights reserved